Lucía Recio-Poveda

Statistics

Publications

Citations

456

H-Index

Active since

2010

Affiliations

Centro de Investigaciones Biológicas Margarita Salas(Current)

Centre for Biomedical Network Research on Rare Diseases

Centro de Investigación Biomédica en Red

Consejo Superior de Investigaciones Científicas

Hospital Universitario Fundación Jiménez Díaz

Lucía Recio-Poveda is an author at Centro de Investigaciones Biológicas Margarita Salas specializing in hereditary hemorrhagic telangiectasia, medicine, and genetics.

Publications per year

2010–2022

Publications

Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response

Luisa Ojeda‐Fernández, Lucía Recio-Poveda, Mikel Aristorena et al. · PLoS Genetics · 2016 · 61 citations · Full text

Life Sciences, Genetics, Immunology +17

Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia

Virginia Albiñana, Lucía Recio-Poveda, Roberto Zarrabeitia et al. · Thrombosis and Haemostasis · 2012 · 57 citations

Medicine, Cardiology, Pharmacotherapy +11

Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-β1 Signaling in Endothelial Cells

Virginia Albiñana, Francisco Sanz-Rodrı́guez, Lucía Recio-Poveda et al. · Molecular Pharmacology · 2011 · 56 citations

Medicine, Genetics, Molecular Genetics +17

Research on potential biomarkers in hereditary hemorrhagic telangiectasia

Luisa M. Botella, Virginia AlbiÃ±ana, Luisa Ojeda‐Fernández et al. · Frontiers in Genetics · 2015 · 41 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease

Virginia Albiñana, Rosa María Jiménez Escribano, Isabel Soler et al. · Orphanet Journal of Rare Diseases · 2017 · 35 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 15